Reversible Inhibitors
Reversible Inhibitors - Related Videos
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
0 Views •
Cited by 15 •
2014
Here we describe cellular cytotoxicity and single round infectivity assays that allow for the rapid and accurate screening of compounds to determine their cellular cytotoxicity (CC50) and IC50 values against WT and drug resistant HIV-1.
01:52
Eukaryotic Transcription Inhibitors
0 Views •
2020
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells. Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
0 Views •
Cited by 3 •
2025
This study used in-silico strategies to identify Enumerated Etravirine as a promising therapeutic agent for HIV. Our findings on molecular interactions and dynamics support the rational design of novel NNRTIs as possible HIV treatment alternatives.
10:33
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
0 Views •
Cited by 4 •
2015
We describe implementation of the REPLACE strategy for targeting protein-protein interactions. REPLACE is an iterative strategy involving synthetic and computational approaches for the conversion of optimized peptidic inhibitors into drug like molecules.
10:10
Reverse Total Shoulder Arthroplasty
0 Views •
Cited by 5 •
2011
Reverse total shoulder arthroplasty is indicated for the treatment of conditions that cannot be treated with conventional arthroplasty or other procedures. These primarily include degenerative and incapacitating conditions with irreparable rotator cuff and loss of the normal biomechanical coupling of the shoulder.
FAQs
The effect depends partly on the inhibitor concentration relative to the target and to competing endogenous ligands or substrates. Increasing exposure can strengthen target inhibition, whereas dilution can reduce the interaction and permit function to return. This concentration dependence helps pharmacologists relate observed potency to target engagement and evaluate how dosing conditions may alter biological responses.
Binding affinity influences how readily an inhibitor associates with an enzyme or receptor and how strongly it competes with other ligands or substrates. A higher-affinity interaction can support inhibition at lower concentrations, while weaker binding may require greater exposure. Considering affinity alongside concentration helps explain differences in potency and supports interpretation of pharmacological effects.
These categories represent distinct inhibition mechanisms that describe how reversible inhibitors affect enzyme or receptor function in relation to active or regulatory sites and competing endogenous ligands or substrates. Identifying the mechanism helps connect molecular interactions with changes in target activity. That distinction is useful when interpreting experiments, comparing compounds, and anticipating how pharmacological responses may vary with exposure.
A basic reversibility assessment compares target activity during inhibitor exposure with activity after the compound is removed or diluted. Recovery of enzyme or receptor function supports a dissociable interaction rather than persistent target inactivation. Researchers can relate the extent and timing of recovery to concentration, affinity, and exposure time when analyzing target engagement or investigating enzyme mechanisms.
Because their target interactions can dissociate, pharmacological effects depend on concentration, affinity, and exposure time rather than on permanent target modification alone. These variables help determine how long inhibition persists and how dosing conditions influence activity. Understanding that relationship supports the design of treatments with controllable target engagement and can help anticipate whether effects may diminish after exposure falls.
Reversible inhibitors provide a way to reduce enzyme or receptor activity while preserving the possibility of functional recovery. In drug discovery, this supports evaluation of potency, duration, and controllability of target engagement. In research, the compounds help analyze enzyme mechanisms and compare interactions at active or regulatory sites, while pharmacological studies use them to investigate dosing and potential reversibility of adverse effects.